Growth Metrics

Vanda Pharmaceuticals (VNDA) FCF Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 10,029.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 723.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,409.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,066.00
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -14,833.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14,833.00
Dec 31, 2025 -6,579.00
Sep 30, 2025 -7,593.00
Jun 30, 2025 -3,810.00
Mar 31, 2025 -7,371.00
Dec 31, 2024 -4,274.00
Sep 30, 2024 -4,436.00
Jun 30, 2024 -4,151.00
Mar 31, 2024 147.00
Dec 31, 2023 -3,591.00
Sep 30, 2023 -2,048.00
Jun 30, 2023 -6,708.00
Mar 31, 2023 5,301.00
Dec 31, 2022 -176.00
Sep 30, 2022 984.00
Jun 30, 2022 -2,576.00
Mar 31, 2022 -1,279.00
Dec 31, 2021 1,019.00
Sep 30, 2021 -400.00
Jun 30, 2021 1,845.00
Mar 31, 2021 1,101.00
Dec 31, 2020 1,971.00
Sep 30, 2020 1,079.00
Jun 30, 2020 4,511.00
Mar 31, 2020 1,339.00
Dec 31, 2019 2,087.00
Sep 30, 2019 792.00
Jun 30, 2019 4,334.00
Mar 31, 2019 3,412.00
Dec 31, 2018 3,209.00
Sep 30, 2018 3,762.00
Jun 30, 2018 -3,419.00
Mar 31, 2018 -1,810.00
Dec 31, 2017 9,669.00
Sep 30, 2017 5,611.00
Jun 30, 2017 33,293.00
Mar 31, 2017 24,733.00
Dec 31, 2016 13,456.00
Sep 30, 2016 11,968.00
Jun 30, 2016 8,822.00
Mar 31, 2016 9,866.00
Dec 31, 2015 17,159.00
Sep 30, 2015 10,264.00
Jun 30, 2015 19,086.00
Mar 31, 2015 15,095.00
Dec 31, 2014 5,926.00
Sep 30, 2014 3,863.00
Jun 30, 2014 -26,416.00
Mar 31, 2014 -21,941.00
Dec 31, 2013 -24,562.00
Sep 30, 2013 -4,799.00